Sidekick Health, which develops digital therapeutics, raised $55 million in a Series B funding round. The company plans to expand its digital treatments to more chronic health conditions. The round was led by Novator Ventures with participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a U.S.-based strategic investor.

The company plans to use the funding to diversify its portfolio and advance the multi-chronic capabilities of its therapeutics platform. It also plans to accelerate its commercial growth in the United States. Sidekick has partnerships with pharmaceutical manufacturers. It also has a digital concierge partnership with the . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Market Watch

A snapshot of what’s happening across the industry—a one-stop source for key developments across policy and regulatory changes, service and treatment innovations, technological advancements, industry recognition and accreditation, mergers and acquisitions, leadership shifts, and more.

Filter Options

  • By Categories
  • By Date Range
  • Sort Date By
  • Results Per Page
Clear Filters

  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.